Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease

Annals of Hematology

Volumn 81, Issue 1, 2002, Pages 20-25

  Weihrauch, Martin R ^a   Re, D ^a   Bischoff, S ^a   Dietlein, M ^a   Scheidhauer, K ^a   Krug, B ^a   Textoris, F ^a   Ansen S ^a   Franklin, J ^a   Bohlen, H ^a   Wolf, J ^a   Schicha, H ^a   Diehl, V ^a   Tesch, H ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Department of Internal Medicine   (Germany)

Author keywords

18F fluorodeoxyglucose (FDG); Hodgkin; Lymphoma; Positron emission tomography (PET); Staging

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ACTIVITY; FEMALE; HODGKIN DISEASE; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING;

ADULT; FEMALE; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036938607     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-001-0390-y     Document Type: Article

References (22)

1. Bangerter M, Griesshammer M, Binder T, Hafner M, Heimpel H, Reske SN, Frickhofen N (1996) New diagnostic imaging procedures in Hodgkin's disease. Ann Oncol 7 [Suppl 4]:55-59
2. Bangerter M, Moog F, Buchmann I, Kotzerke J, Griesshammer M, Hafner M, Elsner K, Frickhofen N, Reske SN, Bergmann L (1998) Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease. Ann Oncol 9:1117-1122
3. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:1860-1861
4. Carde P, Hagenbeek A, Hayat M, Monconduit M, Thomas J, Burgers MJ, Noordijk EM, Tanguy A, Meerwaldt JH, Le Fur R (1993) Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol 11:2258-2272
5. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group [published erratum appears in J Clin Oncol (2000) 18:2351 ]. J Clin Oncol 17:1244
6. Cremerius U, Fabry U, Kroll U, Zimny M, Neuerburg J, Osieka R, Bull U (1999) Clinical value of FDG PET for therapy monitoring of malignant lymphoma - results of a retrospective study in 72 patients (in German). Nuklearmedizin 38:24-30
7. Cremerius U, Fabry U, Neuerburg J, Zimny M, Bares R, Osieka R, Buell U (2001) Prognostic significance of positron emission tomography using fluorine- 18-fluorodeoxyglucose in patients treated for malignant lymphoma. Nuklearmedizin 40:23-30
8. Hamacher K, Coenen HH, Stocklin G (1986) Efficient stereo-specific synthesis of no-carrier-added 2-[18F]-fluoro-2- deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27:235-238
9. Hoh CK, Glaspy J, Rosen P, Dahlbom M, Lee SJ, Kunkel L, Hawkin RA, Maddahi J, Phelps ME (1997) Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med 38:343-348
10. Ingram CE, Belli AM, Lewars MD, Reznek RH, Husband JE (1989) Normal lymph node size in the mediastinum: a retrospective study in two patient groups. Clin Radiol 40:35-39
11. Jerusalem G, Warland V, Najjar F, Paulus P, Fassotte MF, Fillet G, Rigo P (1999) Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma. Nucl Med Commun 20:13-20
12. Leibenhaut MH, Hoppe RT, Efron B, Halpern J, Nelsen T, Rosenberg SA (1989) Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease. J Clin Oncol 7:81-91
13. Lieberz D, Sextro M, Paulus U, Franklin J, Tesch H, Diehl V (2000) How to restrict liver biopsy to high-risk patients in early-stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group. Ann Hematol 79:73-78
14. McLoud TC, Bourgouin PM, Greenberg RW, Kosiuk JP, Templeton PA, Shepard JA, Moore EH, Wain JC, Mathisen DJ, Grillo HC (1992) Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling (see comments). Radiology 182:319-323
15. Moog F, Bangerter M, Diederichs CG, Guhlmann A, Kotzerke J, Merkle E, Kolokythas O, Herrmann F, Reske SN (1997) Lymphoma: role of whole-body 2-deoxy-2-[F-18] fluoro-D-glucose (FDG) PET in nodal staging. Radiology 203:795-800
16. Moog F, Bangerter M, Diederichs CG, Guhlmann A, Merkle E, Frickhofen N, Reske SN (1998) Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology 206:475-481
17. Munker R, Stengel A, Stabler A, Hiller E, Brehm G (1995) Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin's disease. Verification by laparotomy in 100 cases. Cancer 76:1460-1466
18. Newman JS, Francis IR, Kaminski MS, Wahl RL (1994) Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology 190:111-116
19. Partridge S, Timothy A, O'Doherty MJ, Hain SF, Rankin S, Mikhaeel G (2000) 2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution (in process citation). Ann Oncol 11: 1273-1279
20. Sandrasegaran K, Robinson PJ, Selby P (1994) Staging of lymphoma in adults. Clin Radiol 49:149-161
21. Stumpe KD, Urbinelli M, Steinert HC, Glanzmann C, Buck A, von Schulthess GK (1998) Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. Eur J Nucl Med 25:721-728
22. Wiedmann E, Baican B, Hertel A, Baum RP, Chow KU, Knupp B, Adams S, Hor G, Hoelzer D, Mitrou PS (1999) Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease. Leuk Lymphoma 34:545-551